News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ZOLL Medical Corporation (ZOLL) LifeVest Wearable Defibrillator Reduces Total Mortality after Cardiac Revascularization


11/15/2011 6:13:38 AM

AHA Scientific Sessions 2011

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NASDAQ GS: ZOLL), a manufacturer of medical devices and related software solutions, announced that a study demonstrating a reduction in total mortality after cardiac revascularization in patients prescribed a LifeVest® Wearable Defibrillator was presented at the American Heart Association’s Scientific Sessions 2011 in Orlando today.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES